Article
Impact of disease-modifying therapies in adults with concomitant psoriatic and metabolic liver disease with integrated immunoprofiling
2026-07-09
Abstract excerpt
Psoriatic disease (PsD) is associated with metabolic dysfunction-associated steatotic liver disease (MASLD), but the hepatic effects of biologic therapies are unclear. We evaluated paired liver MRI and multi-modal immunoprofiling in PsD patients initiating new systemic therapy. COLIPSO is a prospective cohort of adults with moderate-to-severe psoriasis or psoriatic arthritis (PsA) starting a new conventional synth...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- de59b816-483a-54b6-852b-2548d39fd305
- DOI
- 10.64898/2026.07.06.26357384
